Kanjinti and Pneumonia - a phase IV clinical study of FDA data

Summary:

Pneumonia is reported as a side effect among people who take Kanjinti (trastuzumab-anns), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Perjeta, and have Breast cancer.

The phase IV clinical study analyzes which people have Pneumonia when taking Kanjinti. It is created by eHealthMe based on reports of 1,241 people who have side effects when taking Kanjinti from the FDA, and is updated regularly.

What is Kanjinti?

Kanjinti has active ingredients of trastuzumab-anns. eHealthMe is studying from 1,241 Kanjinti users. Check the latest studies of Kanjinti.

What is Pneumonia?

Pneumonia is found to be associated with 3,355 drugs and 4,677 conditions by eHealthMe. Check the latest studies of Pneumonia.

On Jul, 16, 2026

1,241 people reported to have side effects when taking Kanjinti.
Among them, 12 people (0.97%) have Pneumonia.

Among these 12 people:

How long have people been on Kanjinti when they have Pneumonia? *

What is the gender of people who have Pneumonia when taking Kanjinti? *

female: 100 %
male: 0.0 %

What is the age of people who have Pneumonia when taking Kanjinti? *

What are other drugs people take besides Kanjinti? *

Perjeta: 5 people, 41.67%
Zopiclone: 1 person, 8.33%
Levetiracetam: 1 person, 8.33%
Amoxicillin: 1 person, 8.33%
Anastrozole: 1 person, 8.33%
Chlorpheniramine Maleate: 1 person, 8.33%
Codeine: 1 person, 8.33%
Dexamethasone: 1 person, 8.33%
Docetaxel: 1 person, 8.33%
Enhertu: 1 person, 8.33%

What are other side effects people have besides Pneumonia? *

Fatigue (feeling of tiredness): 2 people, 16.67%
Diarrhea: 2 people, 16.67%
Stomatitis (inflammation of mucous membrane of mouth): 1 person, 8.33%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 1 person, 8.33%
Back Pain: 1 person, 8.33%
Bone Pain: 1 person, 8.33%
Breast Cancer Metastatic: 1 person, 8.33%
Chest Pain: 1 person, 8.33%
Cough: 1 person, 8.33%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 1 person, 8.33%

What are the existing conditions these people have? *

Breast Cancer: 2 people, 16.67%
Breast Cancer Metastatic: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Kanjinti and have Pneumonia?

- Check whether Pneumonia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Kanjinti:

Kanjinti (1,241 reports)

Pneumonia treatments and more:

Pneumonia (433,139 reports)

Browse all side effects of Kanjinti:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pneumonia:

Pneumonia (3,355 drugs)

Browse all the conditions that are associated with Pneumonia:

Pneumonia (4,677 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on trastuzumab-anns (the active ingredients of Kanjinti) and Kanjinti (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.